Aurubis (ETR:NDA) received a €90.00 ($111.11) price target from investment analysts at Kepler Capital Markets in a research report issued on Monday. The firm presently has a “buy” rating on the stock. Kepler Capital Markets’ target price would indicate a potential upside of 12.08% from the stock’s current price.
Several other research analysts have also commented on the company. Berenberg Bank set a €76.00 ($93.83) target price on Aurubis and gave the stock a “neutral” rating in a research report on Thursday. Goldman Sachs Group set a €57.00 ($70.37) target price on Aurubis and gave the stock a “sell” rating in a research report on Thursday. Macquarie set a €66.00 ($81.48) target price on Aurubis and gave the stock a “sell” rating in a research report on Wednesday, January 24th. Deutsche Bank set a €75.00 ($92.59) target price on Aurubis and gave the stock a “neutral” rating in a research report on Monday, January 22nd. Finally, Warburg Research set a €90.00 ($111.11) target price on Aurubis and gave the stock a “buy” rating in a research report on Wednesday, January 17th. Six analysts have rated the stock with a sell rating, six have assigned a hold rating and four have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of €73.48 ($90.71).
Aurubis (ETR:NDA) opened at €80.30 ($99.14) on Monday. The company has a market capitalization of $3,630.00 and a P/E ratio of 10.28. Aurubis has a 12-month low of €51.54 ($63.63) and a 12-month high of €86.80 ($107.16).
Aurubis AG engages in the copper concentrate processing, metal recycling, and copper product fabrication activities in Europe, Asia, the United States, and internationally. It operates in two segments, Primary Copper and Copper Products. The company procures and processes copper concentrates; produces and markets exchange-traded copper cathodes; and produces and markets sulfuric acid, iron silicate, precious metals, and specialty products.
Receive News & Ratings for Aurubis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurubis and related companies with MarketBeat.com's FREE daily email newsletter.